Author

Chiara Lonigro

Ghent UniversityORCID 0000-0002-9523-7929Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:yeast· 2 Research Focus:database / resource· 1 Organism:human· 1 Organism:mouse· 1 Assay:protein sequence· 1 Assay:proteomics· 1

Frequent Co-Authors

Daria FijałkowskaiD· 3 shared Hannah EeckhautiD· 3 shared Loes van SchieiD· 3 shared Nico CallewaertiD· 3 shared Sandrine VanmarckeiD· 3 shared Bert SchepensiD· 2 shared Dirk JochmansiD· 2 shared Dries Van HerpeiD· 2 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMolecular Biology

Daria FijałkowskaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintMar 4, 2024

Yeast-based production platform for potent and stable heavy chain-only antibodies

Chiara Lonigro, Hannah Eeckhaut, Royan Alipour Symakani…·Nico Callewaert

This paper presents a yeast-based platform for producing stable and potent heavy chain-only antibodies, demonstrating its effectiveness with an anti-SARS-CoV-2 example.

DOI 10.1101/2024.03.04.580093

yeastprotein sequence

𝕏 PostBluesky

Molecular BiologybioRxivPreprintDec 13, 2022

OPENPichia: building a free-to-operate Komagataella phaffii protein expression toolkit

Dries Van Herpe, Robin Vanluchene, Kristof Vandewalle…·Nico Callewaert

The paper develops an open-source yeast chassis, OPENPichia, for synthetic biology by reverse engineering and characterizing industrial Pichia strains.

4 citations

yeastexperimental assay

𝕏 PostBluesky

Molecular BiologybioRxivPreprintMar 8, 2021

Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents

Bert Schepens, Loes van Schie, Wim Nerinckx…·Xavier Saelens

The paper describes the development of a broadly neutralizing antibody, XVR011, effective against SARS-CoV-2 and its variants in animal models.

7 citations

mouserat

𝕏 PostBluesky